Kuihua Pharmaceutical Group Co., Ltd. is based on the mission of "guaranteeing the safety of Chinese children's medication, protecting the healthy growth of Chinese children. Being a good medicine for the people and bringing a healthy and beautiful life to hundreds of millions of families". It has a brand OTC product as the core and covers R&D. , well-known pharmaceutical companies in the entire industrial chain.

The group was formerly the former state-owned Wuchang Pharmaceutical Factory in Heilongjiang Province. In 1998, it was reorganized into a private enterprise, Heilongjiang Kuihua Pharmaceutical Co., Ltd., and then continued to grow and grew. In 2005, Kuihua Pharmaceutical Group Co., Ltd. was established. The group currently has 32 subsidiaries including 13 pharmaceutical production enterprises, 6 sales companies, 4 pharmaceutical research institutes, 2 medicinal materials planting bases, and 1 pharmaceutical packaging company. It is headquartered in Harbin City. Listed in Shenzhen at the end of 2014, with stock code: 002737.

The company is currently the executive vice president unit of the All-China Federation of Industry and Commerce Pharmaceutical Industry Chamber of Commerce, the vice president unit of the China Pharmaceutical Enterprise Management Association, the vice president unit of the China Pharmaceutical Business Association, the member unit of the China Traditional Chinese Medicine Association, and the vice president of the Chronic Disease Professional Committee of the China Traditional Chinese Medicine Association Unit, senior vice president unit of China Over-the-counter Drug Association, etc.

Kuihua Pharmaceutical Group is dominated by traditional Chinese medicine, with "chemical drugs, biological drugs" and "healthy and health products" as its two wings, and is in the six major fields of "pediatrics, gynecology, digestive system, respiratory colds, rheumatism and bone diseases, and cardiovascular and cerebrovascular diseases". It has formed a comprehensive layout of product pipelines and has a rich product line, with a total of 21 dosage forms, 257 products in production, and 1,126 drug approval numbers. Among them, nearly 100 children's medicine approval numbers have been held and more than 60 sold drug products. Xiao Kuihua Children's Medicine has unshakable advantages in the same category in the OTC field in terms of "sales scale, product quantity, and scale single products". .

The company is an OTC large-scale enterprise with "dual brand umbrellas". "Sunflower" and "Little Sunflower" have built the consumer trust foundation for the company's adult medicine and children's medicine. After more than 20 years of creation, the company has adopted the combination marketing model of "brand model, general medicine model, prescription model, big health model, new retail model" and other combination marketing models to build a unique combination marketing and full model in the industry. The integration model has attracted attention and imitation in the industry.